The pivotal role of interleukin 6 in formation and function of hematopoietically active murine long-term bone marrow cultures

Stem Cells

Volumn 15, Issue 2, 1997, Pages 125-132

  Hauser, Simon P ^a   Kajkenova, Oumitana ^a   Lipschitz, David A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Bone marrow culture; Horse serum; Interleukin 6; Myelopoiesis; Stroma

Indexed keywords

INTERLEUKIN 6;

ANIMAL TISSUE; ARTICLE; FEMALE; GROWTH REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; MYELOPOIESIS; NONHUMAN; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALIA; EQUUS CABALLUS; MURINAE;

EID: 0030984275     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150125     Document Type: Article

References (43)

1. Van Snick J, Cayphas S, Szikora J-P et al. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol 1988;18:193-197.
2. Gimble JM, Hudson J, Henthorn J et al. Regulation of interleukin 6 expression in murine bone marrow stromal cells. Exp Hematol 1991;19:1055-1060.
3. Guba SC, Sartor CI, Gottschalk LR et al. Bone marrow stromal fibroblasts secrete interleukin-6 and granulocyte-macrophage colony-stimulating factor in the absence of inflammatory stimulation: demonstration by serum-free bioassay, enzyme-linked immunosorbent assay, and reverse transcriptase polymerase chain reaction. Blood 1992;80:1190-1198.
4. Hudak S, Thompson-Snipes L, Rocco C et al. Anti-IL-6 antibodies suppress myeloid cell production and the generation of CFU-C in long-term bone marrow cultures. Exp Hematol 1992;20:412-417.
5. Nemunaitis J, Andrews DF, Mochzuki DY et al. Human marrow stromal cells: response to interleukin-6 (IL-6) and control of IL-6 expression. Blood 1989;74:1929-1935.
6. Kittler ELW, McGrath H, Temeles D et al. Biologic significance of constitutive and subliminal growth factor production by bone marrow stroma. Blood 1992;79:3168-3178.
7. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-278.
8. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
9. Chiu C-P, Moulds C, Coffman RL et al. Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells. Proc Natl Acad Sci USA 1988;85:7099-7103.
10. Suda T, Yamaguchi Y, Suda J et al. Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors. Exp Hematol 1988;16:891-895.
11. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insight into the pathophysiology of osteoporosis. N Eng J Med 1995;332:305-311.
12. Ikebuchi K, Wong GG, Clark SC et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 1987;84:9035-9039.
13. Wong GG, Witek-Giannotti JS, Temple PA et al. Stimulation of murine hematopoietic colony formation by human IL-6. J Immunol 1988;140:3040-3044.
14. Muench MO, Schneider JG, Moore MAS. Interactions among colony-stimulating factors, IL-1β, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells. Exp Hematol 1992;20:339-349.
15. Jacobsen SEW, Ruscetti FW, Okkenhaug C et al. Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro. Exp Hematol 1994;22:1064-1069.
16. Leary AG, Ikebuchi K, Hirai Y et al. Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with Interleukin-1α. Blood 1988;71:1759-1763.
17. Otsuka T, Thacker JD, Hogge DE. The effects of interleukin 6 and interleukin 3 on early hematopoietic events in long-term cultures of human marrow. Exp Hematol 1991;19:1042-1048.
18. Kerst JM, Slaper-Cortenbach ICM, Van der School CE et al. Interleukin-6 is a survival factor for committed myeloid progenitor cells. Exp Hematol 1993;21:1550-1557.
19. Berardi AC, Wang A, Levine JD et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-108.
20. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of hematopoietic stem cells in vitro. J Cell Physiol 1977;91:335-344.
21. Mauch P, Greenberger JS, Botnick L et al. Evidence for structured variation in self-renewal capacity within long-term bone marrow cultures. Proc Natl Acad Sci USA 1980;77:7929-7930.
22. Hauser SP, Waldron JA, Udupa KB et al. Morphological characterization of stromal cell types in hematopoietically active murine long-term bone marrow cultures. J Histochem Cytochem 1995;43:371-379.
23. Worton RG, McCulloch EA, Till JE. Physical separation of hemopoietic stem cells from cells forming colonies in cultures. J Cell Physiol 1969;74:171-182.
24. Van Snick J, Cayphas S, Vnik A et al. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 1986;83:9679-9683.
25. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986;89:271-277.
26. Lipschitz DA, Udupa KB. Effects of donor age on long-term culture of bone marrow in vitro. Mech Ageing Dev 1984;24:119-127.
27. Bernad A, Kopf M, Kulbacki R et al. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1994;1:725-731.
28. Kawano M, Tanaka H, Ishikawa H et al. Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma. Blood 1989;73:2145-2148.
29. Caligaris-Cappio F, Bergui L, Gregoretti MG et al. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 1991;77:2688-2693.
30. Van Oers MHJ, Van Zaanen HCT, Lokhorst HM. Interleukin-6, a new target for therapy in multiple myeloma? Ann Hematol 1993;66:219-223.
31. Ballester OF, Moscinski LC, Lyman GH et al. High levels of interleukin-6 are associated with low level tumor burden and low growth fraction in multiple myeloma. Blood 1994;83:1903-1908.
32. Ishimi Y, Miyaura C, Jin CH et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
33. Jilka RL, Hangoc G, Girasole G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257:88-91.
34. Nemunaitis J, Andrews DF, Crittenden C et al. Response of simian virus 40 (SV40)-transformed cultured human marrow stromal cells to hematopoietic growth factors. J Clin Invest 1989;83:593-601.
35. Elias JA, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 1990;145:161-166.
36. Neta R, Vogel SN, Sipe JD et al. Comparison of in vivo effects of human recombinant IL-1 and human IL-6 in mice. Lymophokine Res 1988;7:403.
37. McIntosh JK, Jablons DM, Mule JJ et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum IL-6 in tumor-bearing mice. J Immunol 1989;143:162-167.
38. Neta R, Perlstein R, Vogel SN et al. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine response to IL-1 and tumor necrosis factor. J Exp Med 1992;175:689-694.
39. Schindler R, Mancilla J, Enders S et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-47.
40. Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured monocytes. U937, and in mice. J Immunol 1989;143:3517-3523.
41. Riedy MC, Stewart CC. Inhibitory role of interleukin-6 in macrophage proliferation. J Leukoc Biol 1992;52:125-127.
42. Lipschitz DA, Udupa KB, Taylor JM et al. Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow cultures. Blood 1987;69:1211-1217.
43. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 1992;79:2821-2826.